The Irish Clinical Oncology Group t/a Cancer Trials Ireland (Cancer Trials Ireland)

Lobbying Organisation The Irish Clinical Oncology Group t/a Cancer Trials Ireland

Date published 20 Jan, 2025

Relevant Matter Public policy or programme

Public Policy Area Health

Period 1 Sep, 2024 to 31 Dec, 2024

Specific Details GDPR & Trials (Dail Question)

Intended results Inform decision makers on issues pertinent to Cancer Clinical Trials

Name of person primarily responsible for lobbying on this activity Ms Eibhlin Mulroe, CEO, Cancer Trials Ireland

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) Yes

Current or Former Designated Public Official(s)

Denis Naughton (Currently employed as a DPO) TD (Dáil Éireann, the Oireachtas)

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Meeting (1)

Deputy Denis Naughten met with CTI CEO, COO and other staff on Sept 30th in RCSI to develop questions about clinical trials in Ireland to raise in the House during Leader’s Questions on October 24th 2024.

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Denis Naughten TD (Dáil Éireann, the Oireachtas)